E-LIB Suche - Ergebnisse für: Boeree, A. (Aurélie)

1

Oncogenic and immunological targets for matched therapy of ..:

Boer, Judith M. ; Ilan, Uri ; Boeree, Aurélie...
HemaSphere. 8 (2024) 7 - p. , 2024

Link: https://doi.org/10.1002/..

2

Targeted treatment options for paediatric B-cell precursor ..:

Michels, Naomi ; Hormann, Femke M. ; Boeree, Aurélie...
EJC Paediatric Oncology. 3 (2024) - p. 100140 , 2024

Link: https://doi.org/10.1016/..

3

Tyrosine kinase inhibitor response of ABL-class acute lymph..:

van Outersterp, Inge ; Tasian, Sarah K. ; Reichert, Caitlin E. J....
Blood. 143 (2024) 21 - p. 2178-2189 , 2024

Link: https://doi.org/10.1182/..

4

Tyrosine kinase inhibitor resistance in de novo BCR::ABL1–p..:

van Outersterp, Inge ; Boer, Judith M. ; van de Ven, Cesca...
Blood Advances. 8 (2024) 8 - p. 1835-1845 , 2024

Link: https://doi.org/10.1182/..

5

Integrating copy number data of 64 iAMP21 BCP-ALL patients ..:

Hormann, Femke M. ; Hoogkamer, Alex Q. ; Boeree, Aurélie...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Characterization of a novel MEF2D-BCL9 fusion positive acut..:

Van Outersterp, Inge ; Hormann, Femke M. ; Hoogkamer, Alex Q....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

7

P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD C..:

Boer, Judith M. ; Ilan, Uri ; Hoen, Babette D.J....
HemaSphere. 7 (2023) S3 - p. e0856830 , 2023

Link: https://doi.org/10.1097/..

8

Ibrutinib is not an effective drug in primografts of TCF3-P..:

van de Ven, Cesca ; Boeree, Aurélie ; Stalpers, Femke..
Translational Oncology. 13 (2020) 10 - p. 100817 , 2020

Link: https://doi.org/10.1016/..

9

Copy number alterations in B-cell development genes, drug r..:

Steeghs, Elisabeth M. P. ; Boer, Judith M. ; Hoogkamer, Alex Q....
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

10

JAK2 aberrations in childhood B-cell precursor acute lympho..:

Steeghs, Elisabeth M.P. ; Jerchel, Isabel S. ; de Goffau-Nobel, Willemieke...
Oncotarget. 8 (2017) 52 - p. 89923-89938 , 2017

Link: https://doi.org/10.18632..

11

Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acu..:

Boer, Judith M. ; Steeghs, Elisabeth M.P. ; Marchante, João R.M....
Oncotarget. 8 (2016) 3 - p. 4618-4628 , 2016

Link: https://doi.org/10.18632..

12

Targeted treatment options for paediatric B-cell precursor ..:

Naomi Michels ; Femke M. Hormann ; Aurélie Boeree...
http://www.sciencedirect.com/science/article/pii/S2772610X23001381. , 2024

Link: https://doi.org/10.1016/..

13

P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD C..:

Boer, Judith M ; Ilan, Uri ; Hoen, Babette D.J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428480/. , 2023

Link: http://www.ncbi.nlm.nih...

14

P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD C..:

Judith M. Boer ; Uri Ilan ; Babette D.J. Hoen...
http://journals.lww.com/10.1097/01.HS9.0000968176.08568.30. , 2023

Link: https://doi.org/10.1097/..

15

Characterization of a novel MEF2D-BCL9 fusion-positive acut..:

van Outersterp, Inge ; Hormann, Femke M ; Hoogkamer, Alex Q...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542830/. , 2023

Link: http://www.ncbi.nlm.nih...